Laninamivir Octanoate Hydrate

辛酸拉尼米韦

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameLaninamivir Octanoate Hydrate
Drug Alias Name那尼纳米韦laninamivirum拉尼那米韦拉尼娜米韦拉那米韦 +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeuraminidase inhibitors
TargetsNeuraminidase
Therapy Area/IndicationsInfluenza A virus infectionsAsthmaInfluenza, Human +[4] 
Global Approved IndicationsInfluenza A virus infectionsInfluenza, HumanInfluenza B virus infection
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date2010/09/10
Country/TerritoryBelgiumBulgariaCanada +[20] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesDaiichi Sankyo Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesDaiichi Sankyo Co Ltd
Inactive CompaniesBiota Scientific Management Pty Ltd
Active IndicationsInfluenza A virus infectionsInfluenza, HumanInfluenza B virus infection
Inactive IndicationsAsthma

Other Information

ATC CodeJ05AH04
Related LinksWikipediaDrugBankKEGG